He, L., Liu, Y., Han, H., Liu, Z., Huang, S., Cao, W., . . . Zhou, F. (2020). Survival Outcomes After Adding Stereotactic Body Radiotherapy to Metastatic Renal Cell Carcinoma Patients Treated With Tyrosine Kinase Inhibitors. Am J Clin Oncol.
Citación estilo ChicagoHe, Liru, et al. "Survival Outcomes After Adding Stereotactic Body Radiotherapy to Metastatic Renal Cell Carcinoma Patients Treated With Tyrosine Kinase Inhibitors." Am J Clin Oncol 2020.
Cita MLAHe, Liru, et al. "Survival Outcomes After Adding Stereotactic Body Radiotherapy to Metastatic Renal Cell Carcinoma Patients Treated With Tyrosine Kinase Inhibitors." Am J Clin Oncol 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.